Approval · Notice of Compliance 7993 · 2006
GLUCOBAY: Notice of Compliance 7993
Issued May 30, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7993
- Date
- May 30, 2006
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product name change from prandase
- Therapeutic class
- Oral antidiabetic agent / alpha-glucosidase inhibitor